Edge Therapeutics Competitors and Similar CompaniesClear all
Edge Therapeutics's competitors and similar companies include Ipsen and Biogen.
 Edge Therapeutics Edge Therapeutics, a clinical-stage biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date 2009 | Founding Date 1929 | Founding Date 1978 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Berkeley Heights, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 10 | Employees 5,358 | Employees 7,605 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €659.1m (FY, 2025) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €3.3b (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ($16.9m) (FY, 2021) | Net income €445.1m (FY, 2025) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company